DaYi Machinery Blog
Fundada em 1996, a Jinan Dayi Extrusion Machinery Co., Ltd tem sido a fabricante profissional e a empresa modelo de máquinas de extrusão de alimentos avançadas e altamente eficientes nesse campo. A DAYI Company reúne uma equipe de especialistas com vinte anos de experiência nesse setor de máquinas de extrusão, não apenas trabalhando duro para pesquisar constantemente a tecnologia de extrusão, mas também explorando processos alimentícios para beneficiar nossos clientes que produzem alimentos criativos.

Products Manufactured by Twin-Screw Extruders: A Comprehensive Overview
The twin-screw extruder (TSE) is a remarkably flexible manufacturing platform. By precisely controlling mechanical shear, temperature, pressure, and residence time, it transforms raw powders and

Applications of Twin-Screw Extruders: A Versatile Processing Tool
Applications of Twin-Screw Extruders: A Versatile Processing Tool The twin-screw extruder (TSE), particularly the co-rotating intermeshing type, has evolved from a simple compounding machine into

Effective Cooling Methods for Extruders
Proper temperature control is critical for extrusion processes, affecting product quality, machine stability, and energy efficiency. snack extruder machine Overheating can lead to material degradation,

Heating Mechanisms in a Twin-Screw Extruder
A twin-screw extruder is a versatile thermal-mechanical processing system used extensively in food, feed, plastics, and biochemical industries. double screw extruder Its heating is crucial

Puffed Breadcrumbs: The Versatile Powerhouse in Modern Food Production
Puffed breadcrumbs, a versatile processed food ingredient, are revolutionizing texture and functionality across culinary sectors. This article explores their production methods, unique properties, and expanding

The Silent Feast: Unpacking the Gold Rush and Hidden Realities of the Pet Food Industry
Introduction: From Scraps to Superfoods The global pet food market, once a quiet corner of the agricultural byproducts industry, has transformed into a high-stakes, multi-billion-dollar